The Innovator Passport: A Step Forward, or Just Another Stamp in the Queue?
In my last blog, I explored the growing appeal of the B2C route in digital health, especially in contrast to the highly attractive but challenging B2B2C strategy that a target as big as the NHS offers, but let’s dig into something often overlooked: how can the latter model actually restrict patient access, rather than enhance it.